S. Frömbling

Dr. S. Frömbling is a researcher affiliated with DESY (Deutsches Elektronen-Synchrotron) specializing in medical research, particularly in autoimmune kidney diseases and podocyte biology. Their work focuses on the mechanistic significance of the ubiquitin proteasome system in autoimmune environments affecting kidney function.

Research interests include podocyte injury mechanisms, ubiquitin C-terminal hydrolase L1 function, and autoimmune glomerulonephritis. Their research examines how non-functional ubiquitin C-terminal hydrolase L1 drives podocyte injury through impairing proteasomes in membranous nephropathy, where autoantibodies target podocytes of the glomerular filter resulting in proteinuria.

Dr. Frömbling has published in high-impact journals, with their most notable work appearing in Nature Communications (2023), which investigated the relationship between proteasome impairment and autoimmune kidney disease. This research represents important contributions to understanding the molecular mechanisms underlying autoimmune kidney disorders.